Peer Review reports
From: Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis
| Original Submission | ||
|---|---|---|
| 24 Jul 2019 | Submitted | Original manuscript |
| 30 Jul 2019 | Author responded | Author comments - Luca Richeldi |
| Resubmission - Version 2 | ||
| 30 Jul 2019 | Submitted | Manuscript version 2 |
| 15 Aug 2019 | Reviewed | Reviewer Report - Gary M. Hunninghake |
| 20 Aug 2019 | Reviewed | Reviewer Report - Paolo Spagnolo |
| 21 Nov 2019 | Author responded | Author comments - Luca Richeldi |
| Resubmission - Version 3 | ||
| 21 Nov 2019 | Submitted | Manuscript version 3 |
| 22 Nov 2019 | Reviewed | Reviewer Report - Paolo Spagnolo |
| 8 Dec 2019 | Reviewed | Reviewer Report - Paola Faverio |
| 11 Dec 2019 | Author responded | Author comments - Luca Richeldi |
| Resubmission - Version 4 | ||
| 11 Dec 2019 | Submitted | Manuscript version 4 |
| Publishing | ||
| 12 Dec 2019 | Editorially accepted | |
| 8 Jan 2020 | Article published | 10.1186/s12890-019-1030-4 |
You can find further information about peer review here.